Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection

Abstract Antimicrobial resistance is a rising global health threat, leading to ineffective treatments, increased mortality and rising healthcare costs. In ICUs, inappropriate empiric antibiotic therapy is often given due to treatment urgency, causing poor outcomes. This study developed a machine lea...

Full description

Saved in:
Bibliographic Details
Main Authors: Ella Goldschmidt, Ella Rannon, Daniel Bernstein, Asaf Wasserman, Michael Roimi, Anat Shrot, Dan Coster, Ron Shamir
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-024-01426-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861580674105344
author Ella Goldschmidt
Ella Rannon
Daniel Bernstein
Asaf Wasserman
Michael Roimi
Anat Shrot
Dan Coster
Ron Shamir
author_facet Ella Goldschmidt
Ella Rannon
Daniel Bernstein
Asaf Wasserman
Michael Roimi
Anat Shrot
Dan Coster
Ron Shamir
author_sort Ella Goldschmidt
collection DOAJ
description Abstract Antimicrobial resistance is a rising global health threat, leading to ineffective treatments, increased mortality and rising healthcare costs. In ICUs, inappropriate empiric antibiotic therapy is often given due to treatment urgency, causing poor outcomes. This study developed a machine learning model to predict the appropriateness of empiric antibiotics for ICU-acquired bloodstream infections, using data from the MIMIC-III database. To address missing values and dataset imbalances, novel computational methods were introduced. The model achieved an AUROC of 77.3% and AUPRC of 40.4% on validation, with similar results on external datasets from MIMIC-IV and Rambam Hospital. The model also predicted mortality risk, identifying a 30% mortality rate in high-risk patients versus 16.8% in low-risk groups. External validation on the eICU database showed a comparable gap, with mortality rates at 24% for high-risk and 7.7% for low-risk groups. Our study demonstrates the potential of machine learning models to predict inappropriate empiric antibiotic treatment.
format Article
id doaj-art-9f614089539f48aa91a015e76e63ace5
institution Kabale University
issn 2398-6352
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series npj Digital Medicine
spelling doaj-art-9f614089539f48aa91a015e76e63ace52025-02-09T12:55:36ZengNature Portfolionpj Digital Medicine2398-63522025-02-018111610.1038/s41746-024-01426-9Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infectionElla Goldschmidt0Ella Rannon1Daniel Bernstein2Asaf Wasserman3Michael Roimi4Anat Shrot5Dan Coster6Ron Shamir7Blavatnik School of Computer Science, Tel-Aviv UniversityThe Shmunis School of Biomedicine and Cancer Research, Tel-Aviv UniversityDepartment of Internal Medicine “E”, Tel-Aviv Sourasky Medical CenterDepartment of Internal Medicine “E”, Tel-Aviv Sourasky Medical CenterIntensive Care Unit, Rambam Health Care CampusIndependent researcherBlavatnik School of Computer Science, Tel-Aviv UniversityBlavatnik School of Computer Science, Tel-Aviv UniversityAbstract Antimicrobial resistance is a rising global health threat, leading to ineffective treatments, increased mortality and rising healthcare costs. In ICUs, inappropriate empiric antibiotic therapy is often given due to treatment urgency, causing poor outcomes. This study developed a machine learning model to predict the appropriateness of empiric antibiotics for ICU-acquired bloodstream infections, using data from the MIMIC-III database. To address missing values and dataset imbalances, novel computational methods were introduced. The model achieved an AUROC of 77.3% and AUPRC of 40.4% on validation, with similar results on external datasets from MIMIC-IV and Rambam Hospital. The model also predicted mortality risk, identifying a 30% mortality rate in high-risk patients versus 16.8% in low-risk groups. External validation on the eICU database showed a comparable gap, with mortality rates at 24% for high-risk and 7.7% for low-risk groups. Our study demonstrates the potential of machine learning models to predict inappropriate empiric antibiotic treatment.https://doi.org/10.1038/s41746-024-01426-9
spellingShingle Ella Goldschmidt
Ella Rannon
Daniel Bernstein
Asaf Wasserman
Michael Roimi
Anat Shrot
Dan Coster
Ron Shamir
Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection
npj Digital Medicine
title Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection
title_full Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection
title_fullStr Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection
title_full_unstemmed Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection
title_short Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection
title_sort predicting appropriateness of antibiotic treatment among icu patients with hospital acquired infection
url https://doi.org/10.1038/s41746-024-01426-9
work_keys_str_mv AT ellagoldschmidt predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT ellarannon predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT danielbernstein predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT asafwasserman predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT michaelroimi predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT anatshrot predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT dancoster predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection
AT ronshamir predictingappropriatenessofantibiotictreatmentamongicupatientswithhospitalacquiredinfection